Molecular epidemiology and mechanisms of antimicrobial resistance in Pseudomonas aeruginosa isolates causing burn wound infection in Iran

References

• Zhanel GG, DeCorby M, Adam H, Mulvey MR, McCracken M, Lagace-Wiens P, et al. Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008). Antimicrob Agents Chemother. 2010;54(11):4684–93.
   PubMed Web of Science ®Google Scholar
• Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA. Attributable hospital cost and length of stay associated with health care associated infections caused by antibiotic-resistant Gram-negative bacteria. Antimicrob Agents Chemother. 2010;54:109–15.
   PubMed Web of Science ®Google Scholar
• Livermore DM. Of Pseudomonas, porins, pumps, and carbapenems. J Antimicrob Chemother. 2001;47(3):247–50.
   PubMed Web of Science ®Google Scholar
• Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother. 2003;47:1681–8.
   PubMed Web of Science ®Google Scholar
• Vahdani M, Azimi L, Asghari B, Bazmi F, Rastegar Lari A. Phenotypic screening of extended-spectrum β-lactamase and metallo-β-lactamase in multidrug-resistant Pseudomonas aeruginosa from infected burns. Ann Burns Fire Disasters. 2012;25(2):78–81.
   PubMedGoogle Scholar
• Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother. 2010;54(3):969–76.
   PubMed Web of Science ®Google Scholar
• Poole K, Frank D, Tolmasky M. Pseudomonas aeruginosa: resistance to the max. Front Microbio. 2011;2(65):1–13.
   PubMed Web of Science ®Google Scholar
• Strateva T, Yordanov D. Pseudomonas aeruginosa – a phenomenon of bacterial resistance. J Med Microbiol. 2009;58(9):1133–48.
   PubMed Web of Science ®Google Scholar
• Endimiani A, Luzzaro F, Pini B, Amicosante G, Rossolini GM, Toniolo AQ. Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum β-lactamase. BMC Infect Dis. 2006;6:52.
   PubMed Web of Science ®Google Scholar
• Mirsalehian A, Feizabadi M, Nakhjavani FA, Jabalameli F, Goli H, Kalantari N. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum β-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients. Burns. 2010;36(1):70–4.
   PubMed Web of Science ®Google Scholar
• Kalantar E, Taherzadeh S, Ghadimi T, Soheili F, Salimizand H, Hedayatnejad A. Pseudomonas aeruginosa, an emerging pathogen among burn patients in Kurdistan Province, Iran. Southeast Asian J Trop Med Public Health. 2012;43(3):712–7.
   PubMed Web of Science ®Google Scholar
• Morita Y, Tomida J, Kawamura K. MexXY multidrug efflux system of Pseudomonas aeruginosa. Front Microbio. 2012;3(408):1–13.
   PubMed Web of Science ®Google Scholar
• Llanes C, Hocquet D, Vogne C, Benali-Baitich D, Neuwirth C, Plésiat P. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob Agents Chemother. 2004;48(5):1797–802.
   PubMed Web of Science ®Google Scholar
• Poole K, Srikumar R. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr Top Med Chem. 2001;1:59–71.
   PubMedGoogle Scholar
• Li H, Luo YF, Williams BJ, Blackwell TS, Xie CM. Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies. Inter J Med Microbiol. 2012;302:63–8.
   PubMed Web of Science ®Google Scholar
• Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol. 2004;42(12):5644–9.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 23rd Informational Supplement M100-S23. Wayne, PA: CLSI; 2013.
   Google Scholar
• Lang BJ, Aaron SD, Ferris W, Hebert PC, MacDonald NE. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with multiresistant strains of Pseudomonas aeruginosa. Am J Respir Crit Care Med. 2000;162:2241–5.
   PubMed Web of Science ®Google Scholar
• Aktaş Z, Poirel L, Salcioğlu M, Ozcan PE, Midilli K, Bal C, et al. PER-1- and OXA-10-like β-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates from intensive care unit patients in Istanbul, Turkey. Clin Microbiol Infect. 2005;11(3):193–8.
   PubMed Web of Science ®Google Scholar
• Bert F, Branger C, Lambert-Zechovsky N. Identification of PSE and OXA β-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J Antimicrob Chemother. 2002;50(1):11–8.
   PubMed Web of Science ®Google Scholar
• Bogaerts P, Huang T, Rodriguez-Villalobos H, Bauraing C, Deplano A, Struelens MJ, et al. Nosocomial infections caused by multidrug-resistant Pseudomonas putida isolates producing VIM-2 and VIM-4 metallo-β-lactamases. J Antimicrob Chemother. 2008;61(3):749–51.
   PubMed Web of Science ®Google Scholar
• Jeong SH, Lee K, Chong Y, Yum JH, Lee SH, Choi HJ, et al. Characterization of a new integron containing VIM-2, a metallo-β-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae. J Antimicrob Chemother. 2003;51(2):397–400.
   PubMed Web of Science ®Google Scholar
• Deschaght P, Baere TD, Simaey LV, Daele SV, Baets FD, Vos DD, et al. Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. BMC Microbiol. 2009;29(9):244–53.
   Web of Science ®Google Scholar
• Oh H, Stenhoff J, Jalal S, Wretlind B. Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains. Microb Drug Resist. 2003;9(4):323–8.
   PubMed Web of Science ®Google Scholar
• Cabot G, Ocampo-Sosa AA, Tubau F, Macia MD, Rodríguez C, Moya B, et al. Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study. Antimicrob Agents Chemother. 2011;55(5):1906–11.
   PubMed Web of Science ®Google Scholar
• Pfaffi MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):2003–7.
   PubMed Web of Science ®Google Scholar
• Feil EJ, Enright MC. Analyses of clonality and the evolution of bacterial pathogens. Curr Opin Microbiol. 2004;7:308–13.
   PubMed Web of Science ®Google Scholar
• Samuelsen O, Toleman MA, Sundsfjord A, Rydberg J, Leegaard TM, Walder M, et al. Molecular epidemiology of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother. 2010;54(1):346–52.
   PubMed Web of Science ®Google Scholar
• Empel J, Filczak K, Mrowka A, Hryniewicz W, Livermore DM, Gniadkowski M. Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum β-lactamase in Warsaw, Poland: further evidence for an international clonal complex. J Clin Microbiol. 2007;45(9):2829–34.
   PubMed Web of Science ®Google Scholar
• Yousefi S, Nahaei MR, Farajnia S, Aghazadeh M, Iversen A, Edquist M, et al. A multiresistant clone of Pseudomonas aeruginosa sequence type 773 spreading in a burn unit in Orumieh, Iran. APMIS. 2013;121(2):146–52.
   PubMed Web of Science ®Google Scholar
• Quale J, Bratu S, Gupta J, Landman D. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother. 2006;50:1633–41.
   PubMed Web of Science ®Google Scholar
• Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933–51.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657–86.
   PubMed Web of Science ®Google Scholar
• Bouthors AT, Dagoneau N, Blanchard S, Naas T, Nordmann P, Jarlier V, et al. Role of residues 104, 164, 166, 238, 240 in the substrate profile of PER-1 β-lactamase hydrolysing third-generation cephalosporins. Biochem J. 1998;330:1443–9.
   PubMed Web of Science ®Google Scholar
• Poirel L, Naas T, Guibert M, Chaibi EB, Labia R, Nordmann P. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene. Antimicrob Agents Chemother. 1999;43:573–81.
   PubMed Web of Science ®Google Scholar
• Hocquet D, Roussel-Delvallez M, Cavallo JD, Plesiat P. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin. Antimicrob Agents Chemother. 2007;51:1582–3.
   PubMed Web of Science ®Google Scholar